YAP1 and metabolic dysfunction-associated steatotic liver disease: The results identify a CSN6‐HMGCS1‐YAP1 axis mediating tumor outgrowth in hepatocellular carcinoma (HCC) and propose a therapeutic strategy of targeting non‐alcoholic fatty liver diseases‐associated HCC.